Search

Author/Creator Sharma, P.

2. 151P Clinical outcome and preliminary immune analysis of phase II clinical trial of combination of tocilizumab with ipilimumab and nivolumab for patients with treatment naïve metastatic melanoma. (December 2022)

Authors:
Montazari, E.J.J.; Abdel-Wahab, N.; Johnson, D.; Spillson, C.; Elsayes, K.M.; Duan, F.; Yadav, S.; Allison, J.; Sharma, P.; Diab, A.
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 3LBA CheckMate 025: a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC). (September 2015)

Authors:
Sharma, P.; Escudier, B.; McDermott, D.F.; George, S.; Hammers, H.J.; Srinivas, S.; Tykodi, S.S.; Sosman, J.A.; Procopio, G.; Plimack, E.R.; Castellano, D.; Gurney, H.; Donskov, F.; Bono, P.; Wagstaff, J.; Gauler, T.C.; Ueda, T.; Xu, L.A.; Waxman, I.M.; Motzer, R.J.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S708
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗